NHMRC Clinical Trials Centre

04/08/2021

Today we celebrate and welcome the launch of a new clinical trial research program and fresh hope for Australians facing blood cancer. The Blood Cancer Genomics Trial (MoSTLLy) research program will offer access to genomic screening and potential access to precision medicines for those diagnosed with some aggressive types of blood cancer like high-grade lymphomas and acute leukemia.

12/07/2021

Congratulations to the LEAP1 study team on reaching their recruitment target of 800 patients. The study aims to see if giving the drug givbovine lactoferrin during pregnancy improves foetal growth and neonatal iron status at birth.

28/06/2021

A study from CTC's Professor of Biostatistics, Ian Marschner, has found that the risk of death after the diagnosis of a COVID-19 infection during Victoria’s 2020 outbreaks was 4 percent overall but was estimated to be 10 times higher among the elderly.

The data analytics study, published in BMC Medical Research Methodology, is a comprehensive assessment of COVID-19 mortality prior to the introduction of vaccines in the state of Victoria, Australia, focusing particularly on the impact of age.

The findings demonstrate how modelling and data analytics can help answer key questions on COVID-19 infection in an Australian context. This can help guide global surveillance and the development of strategies to forecast and control the pandemic.

Head to the CTC website to find out more.

10/05/2021

We are on our way! Our INTEGRATE IIb study in collaboration with AGITG activated its first site at Coffs Harbour Health Campus last week and has randomised its first patient. One step closer to improving health outcomes for people with . Congratulations to the team!

21/04/2021

Does symptom monitoring with feedback help to improve quality of life for people on ? Our SWIFT trial with ANZDATA Registry aims to answer this important question in Kidney Health.

First two sites activated are Lismore Base and Gosford Hospitals. Congrats to the SWIFT team! Clinical Lead: Prof Rachael Morton & ANZDATA Executive Officer: Stephen McDonald

20/04/2021

How long have I got? CTC's Dr Belinda Kiely talks to Dr Norman Swan about the recent enhancements made to the cancer survival rates website: www.cancersurvivalrates.com which helps to communicate information about cancer prognosis.

Doctors are sometimes not the best at giving patients an accurate or realistic prognosis about a disease. Yet someone with a cancer diagnosis will most often want to know 'how long have I got'. A US site called aims to give patients and health care professionals accurate information on prognosis by....

07/04/2021

Cancersurvivalrates.com is a 'conversation starter' to help patients know what to ask their physicians. CTC's Director of Oncology, Professor Martin Stockler and Research Fellow Dr Belinda Kiely have shared their extensive expertise with Cancersurvivalrates.com to enhance the site to include survival scenarios and 10 year survival rates. https://cancersurvivalrates.medium.com/cancersurvivalrates-its-been-quite-a-year-6f3b4d304e84

22/03/2021

Neuro endocrine carcinomas are rare affecting less than 1% of the population. The trial aims to investigate a new treatment option, the disease itself & the tumour tissue. Help us find a cure.

Watch video

NABNEC is an Australian Clinical trial for Neuroendocrine Carcinoma patients.This video was made in collaboration with the Australasian Gastro-Intestinal Tri...

08/03/2021

This International Women's Day we celebrate the achievements and dedication of our 200+ incredible female staff who work tirelessly towards improving global health outcomes through excellence in clinical trials and related research.

31/01/2021

Join us for the fourth webinar in our Series...

COSTS AND BENEFITS OF GENOMIC SEQUENCING

Wednesday 17 Feb | 12:30-1:45pm

A seminar series covering trending topics in health economics brought to you by the NHMRC Clinical Trials Centre, Health Economics Team.

25/01/2021

CTC Director Professor Meg Jardine talks to ABC News reporter Sophie Scott about the promising study which looks at potential of common blood-pressure meds to shorten severity of . Recruiting in India & Australia.
Collaboration between NHMRC Clinical Trials Centre, University of Sydney, The George Institute Global, and the George Institute India
Read article -

Australian researchers are among global efforts to develop potential treatments as the world waits for a comprehensive vaccine rollout.

18/01/2021

Do you have a strong desire to work in clinical trials and a passion for quality research? The NHMRC Clinical Trials Centre based at The University of Sydney is hiring. Both academic and professional roles available. Visit our website for more information.